stemcellres.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Stem Cell Research & Therapy
official impact factor 3.21
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Stem Cell Research & Therapy
  • Subscriptions

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
  • Issues
  • Article collections
Please provide a volume number.

Page 4 of 9

 Previous 1 2 3 4 5 6 7 8 9  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

Research   Open Access Highly Accessed

A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction

Aidan Flynn, Xizhe Chen, Enda O'Connell, Timothy O'Brien Stem Cell Research & Therapy 2012, 3:36 (13 September 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The administration of guided unrestricted somatic stem cells had a moderately beneficial effect on cardiac function in a rat model of acute myocardial infarction, showing greater benefit than mesenchymal stem cells.

Review   Subscription Highly Accessed

Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases

Hsiang-Po Huang, Ching-Yu Chuang, Hung-Chih Kuo Stem Cell Research & Therapy 2012, 3:34 (28 August 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Hung-Chih Kuo and colleagues review recent advances in the use of induced pluripotent stem cells (iPSCs) for disease modelling and drug screening in lysosomal storage diseases (LSDs).

Research   Open Access Highly Accessed

Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration

Christopher SD Lee, Olivia A Burnsed, Vineeth Raghuram, Jonathan Kalisvaart, Barbara D Boyan, Zvi Schwartz Stem Cell Research & Therapy 2012, 3:35 (24 August 2012)

Abstract | Full text | PDF | PubMed | F1000 Biology |  Editor’s summary

Adipose stem cells (ASCs) secrete factors that can inhibit cartilage regeneration, and must be pre-treated or modified to reduce these effects before they may be used as a therapy to repair cartilage.

Review   Subscription Highly Accessed

Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells

Christina L O'Neill, Michelle T O'Doherty, Sarah EJ Wilson, Amer A Rana, Claire E Hirst, Alan W Stitt, Reinhold J Medina Stem Cell Research & Therapy 2012, 3:31 (16 August 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Reinhold Medina and colleagues examine the clinical potential of stem and progenitor cells to regenerate damaged vasculature and restore blood flow to ischemic tissues, focusing on endothelial progenitor cells.

Research   Open Access Highly Accessed

Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice

Maik MA Worlitzer, Eva C Bunk, Kathrin Hemmer, Jens C Schwamborn Stem Cell Research & Therapy 2012, 3:33 (14 August 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Anti-inflammatory treatment activates adult neural stem cells leading to regenerative oligodendrogenesis in a parkinsonian mouse model, providing further evidence that controlling neuroinflammation is important in clinical approaches on Parkinson's disease.

Commentary   Subscription

Heart bailout by cell therapy: introducing an acceptable test for comparing cell accountability

Paolo Madeddu Stem Cell Research & Therapy 2012, 3:32 (14 August 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Cell therapy for cardiovascular disease holds a lot of promise, but results in clinical trials have been disappointing; Paolo Madeddu discusses the need to identify appropriate cell types for promoting angiogenesis.

Research   Open Access Highly Accessed

Genetic background affects induced pluripotent stem cell generation

Lauren V Schnabel, Christian M Abratte, John C Schimenti, Teresa L Southard, Lisa A Fortier Stem Cell Research & Therapy 2012, 3:30 (3 August 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Genetic background affects both the efficiency of induced pluripotent stem cell (iPSC) generation and the pluripotent stability of cells during the later stages of reprogramming.

Research   Open Access

Human foreskin fibroblast produces interleukin-6 to support derivation and self-renewal of mouse embryonic stem cells

Yu Ma, Junjie Gu, Chunliang Li, Xiaoyuan Wei, Fan Tang, Guilai Shi, Jing Jiang, Ying Kuang, Jinsong Li, Zhugang Wang, Xin Xie, Ying Jin Stem Cell Research & Therapy 2012, 3:29 (31 July 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Human foreskin fibroblasts (HFF) produce interleukin-6 to support the derivation and maintenance of mouse embryonic stem cell (ESC) lines, providing a convenient, efficient and inexpensive ESC culture system.

Review   Subscription Highly Accessed

Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia

Aaron Liew, Timothy O'Brien Stem Cell Research & Therapy 2012, 3:28 (30 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Aaron Liew and Timothy O'Brien discuss the potential of mesenchymal stem cell (MSC)-based therapy for critical limb ischemia (CLI), including results in animal models and early-phase human trial data.

Editorial   Free Highly Accessed

Stem cells and regenerative medicine

Mahendra Rao Stem Cell Research & Therapy 2012, 3:27 (9 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Mahendra Rao introduces a new series on clinical applications of stem cells, discussing the progress made in taking stem cells from the bench to the bedside and the challenges remaining.

Review   Subscription

The Aastrom experience

Ronnda L Bartel, Caryn Cramer, Kelly Ledford, Amy Longcore, Christopher Parrish, Theresa Stern, Sharon Watling, Frank Zeigler Stem Cell Research & Therapy 2012, 3:26 (9 July 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Ronnda Bartel and colleagues describe their experience manufacturing an autologous differentiated cell product for the treatment of critical limb ischemia.

Review   Subscription Highly Accessed

Mesenchymal stem cells for cartilage repair in osteoarthritis

Pawan K Gupta, Anjan K Das, Anoop Chullikana, Anish S Majumdar Stem Cell Research & Therapy 2012, 3:25 (9 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

The use of bone marrow stromal cells for cartilage repair and their therapeutic potential in osteoarthritis is discussed by Anish Majumdar and colleagues.

Review   Subscription Highly Accessed

Stem cell therapy for the spinal cord

Eleanor M Donnelly, Jason Lamanna, Nicholas M Boulis Stem Cell Research & Therapy 2012, 3:24 (9 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Nicholas Boulis and colleagues review clinical trials of stem cell transplantation into the spinal cord focusing on motor neuron diseases and spinal cord injury and discuss the optimization of delivery methods.

Research   Open Access

Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization

G Robin Barclay, Olga Tura, Kay Samuel, Patrick WF Hadoke, Nicholas L Mills, David E Newby, Marc L Turner Stem Cell Research & Therapy 2012, 3:23 (3 July 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Hematopoietic progenitor cell (HPC) therapy for vascular regeneration works predominantly due to indirect proangiogenic effects rather than direct incorporation of endothelial progenitor cells, which are very rare in HPC sources.

Research   Open Access Highly Accessed

SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells

Jagadeesh K Venkatesan, Myriam Ekici, Henning Madry, Gertrud Schmitt, Dieter Kohn, Magali Cucchiarini Stem Cell Research & Therapy 2012, 3:22 (28 June 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Transfer of SOX9 via replication-defective recombinant adeno-associated virus (rAAV) vector enhances the chondrogenic potential of human mesenchymal stem cells, with potential for future therapeutic applications to restore articular cartilage defects.

Review   Subscription Highly Accessed

Mesenchymal stem cell therapy for attenuation of scar formation during wound healing

Wesley M Jackson, Leon J Nesti, Rocky S Tuan Stem Cell Research & Therapy 2012, 3:20 (31 May 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Editor-in-Chief Rocky Tuan and colleagues review the use of mesenchymal stem cells (MSCs) to promote scar-less wound healing, including the mechanisms by which they can limit tissue fibrosis.

Research   Open Access

Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis

Ena Banerjee, William Henderson Stem Cell Research & Therapy 2012, 3:21 (29 May 2012)

Abstract | Full text | PDF | PubMed

Commentary   Subscription

Can a young muscle's stem cell secretome prolong our lives?

Karl JA McCullagh Stem Cell Research & Therapy 2012, 3:19 (28 May 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Karl McCullagh comments on recent findings that a population of muscle stem cells are able to prolong life in a mouse model of premature ageing.

Review   Free

Strategies for enrichment and selection of stem cell-derived tissue precursors

Harold S Bernstein, William C Hyun Stem Cell Research & Therapy 2012, 3:17 (10 May 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Bernstein and Hyun review strategies used to direct tissue-specific differentiation of embryonic stem cells (ESCs), and methods for the identification and selection of tissue-specific precursors for scientific study and clinical use.

Research   Open Access

The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations

Carlos A Ribeiro, Joana S Fraga, Mário Grãos, Nuno M Neves, Rui L Reis, Jeffrey M Gimble, Nuno Sousa, António J Salgado Stem Cell Research & Therapy 2012, 3:18 (2 May 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The secretome of human umbilical cord perivascular cells (HUPVCs) and adipose tissue-derived stem cells differ, with HUPVC conditioned media able to promote neuronal survival and differentiation without exogenous supplement.

Editorial   Free

Stem Cell Research & Therapy in 2012

Philippa Locke, Rocky S Tuan, Timothy O'Brien Stem Cell Research & Therapy 2012, 3:16 (30 April 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Commentary   Free

Colonizing the heart from the epicardial side

Nenad Bursac Stem Cell Research & Therapy 2012, 3:15 (30 April 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Nenad Bursac comments on recent research describing a distinct population of epicardium-derived mesenchymal stem cells residing in a perivascular niche of the heart with a broad multilineage potential, and considers future applications.

Review   Free

Orthopaedic applications of nanoparticle-based stem cell therapies

Ian Wimpenny, Hareklea Markides, Alicia J El Haj Stem Cell Research & Therapy 2012, 3:13 (19 April 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Alicia El Haj and colleagues review recent research on the applications of iron-oxide-based magnetic nanoparticles to improve how stem cells are controlled, monitored and targeted to sites of repair.

Research   Open Access Highly Accessed

Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome

Xiaoning Mou, Yuanbo Wu, Henghua Cao, Qingzhang Meng, Qihui Wang, Chengchao Sun, Shengshou Hu, Yue Ma, Hao Zhang Stem Cell Research & Therapy 2012, 3:14 (18 April 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The derivation of induced pluripotent stem cells (iPSCs) from two patients with different karyotypes of Down syndrome offers opportunities for disease modeling, drug discovery and potential future cell replacement therapies.

Review   Free Highly Accessed

Progress on stem cell research towards the treatment of Parkinson's disease

Stuart AJ Gibson, Guo-Dong Gao, Katya McDonagh, Sanbing Shen Stem Cell Research & Therapy 2012, 3:11 (3 April 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Sanbing Shen and colleagues provide an overview of recent progress towards a combined approach of drugs, cell replacement, and gene therapy to halt disease progression and improve treatment of Parkinson's disease.

Page 4 of 9

 Previous 1 2 3 4 5 6 7 8 9  Next


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.